Literature DB >> 10751094

Molecular cytogenetic studies in three patients with partial trisomy 2p, including CGH from paraffin-embedded tissue.

A Aviram-Goldring1, B Fritz, C Bartsch, E Steuber, M Daniely, D Lev, R Chaki, G Barkai, M Frydman, H Rehder.   

Abstract

We report on three cases of partial trisomy 2p in which the identification and exact localization of the duplicated chromosome segment was possible only by application of molecular cytogenetic techniques. These included fluorescence in situ hybridization by use of wcp2, N-myc, and subtelomeric 2p probes and comparative genomic hybridization with DNA isolated from blood samples, frozen fetal tendon, and formalin fixed, paraffin-embedded fetal lung tissue. Two of the cases concerned fetuses of gestational week 20 and 24 with duplication of nonoverlapping terminal (2pter-->p24) and more proximal (2p25-->p23) segments and with distinctly different phenotypes. The third case was due to a de novo inverted duplication of 2p25-->p23, with loss of the subtelomeric region of 2p. This 53-month-old girl was a Bloom syndrome carrier. The patient had prenatal growth failure, borderline microcephaly, dilated lateral horns of the cerebral ventricles, transient cortical blindness, myopia, muscle hypotonia, and dilatation of the left renal collecting system. Dermal cysts were found on the glabella, the soles of both feet, and the vocal cord, causing respiratory embarrassment. Previously reported cases of pure trisomy 2p are reviewed, in an attempt to correlate clinical findings to overlapping regions in 2p. These cases illustrate the effectiveness of molecular cytogenetic methods in resolving subtle chromosomal aberrations in order to coordinate more accurately a chromosome regionspecific phenotype.

Entities:  

Mesh:

Year:  2000        PMID: 10751094     DOI: 10.1002/(sici)1096-8628(20000306)91:1<74::aid-ajmg14>3.0.co;2-o

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  High resolution comparative genomic hybridisation in clinical cytogenetics.

Authors:  M Kirchhoff; H Rose; C Lundsteen
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

2.  Duplication 2p25 in a child with clinical features of CHARGE syndrome.

Authors:  Ethan D Sperry; Jane L Schuette; Conny M A van Ravenswaaij-Arts; Glenn E Green; Donna M Martin
Journal:  Am J Med Genet A       Date:  2016-02-06       Impact factor: 2.802

3.  A familial inverted duplication/deletion of 2p25.1-25.3 provides new clues on the genesis of inverted duplications.

Authors:  Maria Clara Bonaglia; Roberto Giorda; Angelo Massagli; Rita Galluzzi; Roberto Ciccone; Orsetta Zuffardi
Journal:  Eur J Hum Genet       Date:  2008-09-24       Impact factor: 4.246

4.  An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism.

Authors:  Michael R Bowl; M Andrew Nesbit; Brian Harding; Elaine Levy; Andrew Jefferson; Emanuela Volpi; Karine Rizzoti; Robin Lovell-Badge; David Schlessinger; Michael P Whyte; Rajesh V Thakker
Journal:  J Clin Invest       Date:  2005-09-15       Impact factor: 14.808

5.  Interstitial microduplication at 2p11.2 in a patient with syndromic intellectual disability: 30-year follow-up.

Authors:  Kyung Ran Jun; Reinhard Ullmann; Saadullah Khan; Lawrence C Layman; Hyung-Goo Kim
Journal:  Mol Cytogenet       Date:  2014-08-19       Impact factor: 2.009

6.  Fetal Cystic Hygroma Associated with Terminal 2p25.1 Duplication and Terminal 3p25.3 Deletion: Cytogenetic, Fluorescent in Situ Hybridization and Microarray Familial Characterization of Two Different Chromosomal Structural Rearrangements.

Authors:  F Stipoljev; M Barbalic; M Logara; A Vicic; M Vulic; S Zekic Tomas; R Gjergja Juraski
Journal:  Balkan J Med Genet       Date:  2021-03-23       Impact factor: 0.519

7.  Sox11 is required to maintain proper levels of Hedgehog signaling during vertebrate ocular morphogenesis.

Authors:  Lakshmi Pillai-Kastoori; Wen Wen; Stephen G Wilson; Erin Strachan; Adriana Lo-Castro; Marco Fichera; Sebastiano A Musumeci; Ordan J Lehmann; Ann C Morris
Journal:  PLoS Genet       Date:  2014-07-10       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.